11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2004
-
Mark
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
(
- Contribution to journal › Article
-
Mark
Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Nove matrix metaloproteinazy v cyklickem endometriu
(
- Contribution to journal › Article
-
Mark
Exprese MMP-26 v endometrialnich explantech pod vlivem estradiolu a progesteronu
(
- Contribution to journal › Article
-
Mark
Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium
(
- Contribution to journal › Article
-
Mark
Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
- 2001
-
Mark
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »